Coalition For Epidemic Preparedness Innovations Us Cepi Us is located in Washington, DC. The organization was established in 2018. According to its NTEE Classification (S80) the organization is classified as: Community Service Clubs, under the broad grouping of Community Improvement & Capacity Building and related organizations. As of 12/2023, Coalition For Epidemic Preparedness Innovations Us Cepi Us employed 32 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Coalition For Epidemic Preparedness Innovations Us Cepi Us is a 501(c)(4) and as such, is described as a "Civic League, Social Welfare Organization, and Local Association of Employees" by the IRS.
For the year ending 12/2023, Coalition For Epidemic Preparedness Innovations Us Cepi Us generated $6.6m in total revenue. This organization has experienced exceptional growth, as over the past 6 years, it has increased revenue by an average of 36.1% each year . All expenses for the organization totaled $6.6m during the year ending 12/2023. While expenses have increased by 36.1% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
CEPI US IS A REGISTERED NON-PROFIT CORPORATION THAT SUPPORTS SOCIAL WELFARE (SEE SCH O) IN ACCORDANCE WITH SECTION 501(C)(4) OF THE US INTERNAL REVENUE CODE OF 1986. IN FURTHERANCE OF SUCH PURPOSES, CEPI US SHALL ENGAGE ACTIVITIES PROMOTING THE OBJECTIVES OF COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS (CEPI), AN INTERNATIONAL NON-PROFIT ORGANIZATION FORMED TO WORK TOWARDS A WORLD IN WHICH EPIDEMICS AND PANDEMICS ARE NO LONGER A THREAT TO HUMANITY, BY ACCELERATING THE DEVELOPMENT, MANUFACTURE AND STOCKPILING OF VACCINES AND SELECT BIOLOGICALS NECESSARY TO RESPOND TO EMERGING INFECTIOUS DISEASES FOR WHICH THERE IS MARKET FAILURE, OR NO COMMERCIAL MARKETS EXIST.
Describe the Organization's Program Activity:
Part 3 - Line 4a
IN A WORLD CHARACTERIZED BY INCREASING POPULATION DENSITY, HUMAN MOBILITY, AND ECOLOGICAL CHANGE, EMERGING INFECTIOUS DISEASES POSE A REAL AND GROWING THREAT TO GLOBAL HEALTH SECURITY. EPIDEMIC DISEASES AFFECT EVERYBODY, AND DO NOT RESPECT BORDERS. VACCINES ARE ONE OF THEMOST POWERFUL TOOLS IN THE FIGHT TO OUTSMART EPIDEMICS. CEPI US'S MISSION IS TO STIMULATE AND ACCELERATE THE DEVELOPMENT OF VACCINES AGAINST EMERGING INFECTIOUS DISEASES AND ENABLE EQUITABLE ACCESS TO THESE VACCINES FOR AFFECTED POPULATIONS DURING OUTBREAKS. CEPI IS AN INNOVATIVE GLOBAL COALITION OF PUBLIC, PRIVATE, PHILANTHROPIC, AND CIVIL SOCIETY ORGANIZATIONS WITH WHOM WE WORK IN PARTNERSHIP CLOSE COLLABORATION WITH GLOBAL PARTNERS WILL BE CRUCIAL TO THE SUCCESS OF CEPIS WORK TO DEVELOP VACCINES AGAINST EMERGING (SEE SCHEDULE O) INFECTIOUS DISEASES. THEREFORE, CEPI WILL SUPPORT COORDINATING ACTIVITIES TO IMPROVE OUR COLLECTIVE RESPONSE TO EPIDEMICS, STRENGTHENING CAPACITY IN COUNTRIES AT RISK, AND ADVANCING THE REGULATORY SCIENCE THAT GOVERNS PRODUCT DEVELOPMENT.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Richard Hatchett Director, CEO | OfficerTrustee | 2 | $0 |
Mads Hogholen Director, Treasurer | OfficerTrustee | 1 | $0 |
Christopher T Da Costa Project Leader, R&d | OfficerTrustee | 40 | $264,600 |
In-Kyu Yoon Director Of Progs And Innov Tech | 40 | $314,700 | |
Nicole Lurie Director, President | 40 | $291,428 | |
Monina Vierneza Secretary | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $6,499,849 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $0 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $6,499,849 |
Total Program Service Revenue | $0 |
Investment income | $94,409 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $6,594,258 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $1,521,541 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $3,430,082 |
Pension plan accruals and contributions | $377,429 |
Other employee benefits | $262,679 |
Payroll taxes | $313,491 |
Fees for services: Management | $0 |
Fees for services: Legal | $1,892 |
Fees for services: Accounting | $72,950 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $5,209 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $119,114 |
Information technology | $11,510 |
Royalties | $0 |
Occupancy | $288,693 |
Travel | $117,555 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $24,725 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $15,143 |
Insurance | $14,838 |
All other expenses | $0 |
Total functional expenses | $6,594,258 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $3,585,245 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $34,449 |
Net Land, buildings, and equipment | $120,652 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $3,740,346 |
Accounts payable and accrued expenses | $3,740,346 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $3,740,346 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $3,740,346 |